There are three breast cancer subtypes based on the status of hormone receptor (HR) and human epidermal growth factor receptor 2 (HER2), i.e., HR-positive, HER2-positive, and triple-negative breast cancer (TNBC) [2]. Here, ERBB2 is linked to triple-negative breast carcinoma.